New evidence suggests decreased mortality could outweigh an elevated risk for hyperkalemia in patients heart failure treated with RAS inhibitors or mineralocorticoid receptor agonists.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/reduced-mortality-may-offset-hyperkalemia-risk-optimal-ras-2025a1000qjw?src=rss
Author :
Publish date : 2025-10-03 06:15:00
Copyright for syndicated content belongs to the linked Source.
